metralindole has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dhuayan, I; ALaqeel, NK | 1 |
1 other study(ies) available for metralindole and Lung Neoplasms
| Article | Year |
|---|---|
Molecular docking, ADMET and molecular dynamics simulation revealed metralindole as a multitargeted inhibitor for division kinases.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation | 2023 |